Literature DB >> 17883368

Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances.

Farrukh A Chaudhry1, Robert H Edwards, Frode Fonnum.   

Abstract

Exocytotic release of neurotransmitters requires their accumulation inside preformed secretory vesicles. Distinct vesicular transport activities translocate classical transmitters into synaptic vesicles energized by a H+ electrochemical gradient (Delta(mu(H+))), with subtle but important differences in dependence on the electrical and chemical components. The vesicular transporters also interact with toxic compounds and drugs. They mediate neuroprotection by sequestering toxic compounds as well as neurotransmitters into vesicles, reducing their concentration in the cytosol where they may have detrimental effects. Both therapeutic agents and psychostimulants interfering with vesicular transport have yielded insight into the pathogenesis of psychiatric as well as neurodegenerative diseases. Thus, specific inhibitors have helped to characterize both the physiological role and mechanism of vesicular neurotransmitter transport.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17883368     DOI: 10.1146/annurev.pharmtox.46.120604.141146

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  32 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 3.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

4.  A putative vesicular transporter expressed in Drosophila mushroom bodies that mediates sexual behavior may define a neurotransmitter system.

Authors:  Elizabeth S Brooks; Christina L Greer; Rafael Romero-Calderón; Christine N Serway; Anna Grygoruk; Jasmine M Haimovitz; Bac T Nguyen; Rod Najibi; Christopher J Tabone; J Steven de Belle; David E Krantz
Journal:  Neuron       Date:  2011-10-20       Impact factor: 17.173

5.  Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.

Authors:  Dana Yaffe; Ariela Vergara-Jaque; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

6.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Activation of lysosomal P2X4 by ATP transported into lysosomes via VNUT/SLC17A9 using V-ATPase generated voltage gradient as the driving force.

Authors:  Xi Zoë Zhong; Qi Cao; Xue Sun; Xian-Ping Dong
Journal:  J Physiol       Date:  2016-05-29       Impact factor: 5.182

8.  Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Authors:  Dana Yaffe; Sebastian Radestock; Yonatan Shuster; Lucy R Forrest; Shimon Schuldiner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

9.  The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.

Authors:  Christina N Carrigan; Sarjubhai A Patel; Holly D Cox; Erin S Bolstad; John M Gerdes; Wesley E Smith; Richard J Bridges; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2013-12-25       Impact factor: 2.823

10.  Schizophrenia: the "BLOC" may be in the endosomes.

Authors:  Pearl V Ryder; Victor Faundez
Journal:  Sci Signal       Date:  2009-10-20       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.